Lactate oxidase (LctO) acts as a metabolic checkpoint restraining Streptococcus pneumoniae invasion of respiratory epithelial barriers
Streptococcus pneumoniae rapidly translocates across polarized human bronchial epithelial barriers, with viable bacteria recovered from the basolateral compartment within 1 h post-infection. Disruption of the pyruvate node through combined deletion of pyruvate oxidase ( spxB ) and lactate oxidase ( lctO ) markedly enhanced transmigration of S. pneumoniae across polarized Calu-3 monolayers without causing early cytotoxicity or loss of monolayer integrity. This hyper-invasive phenotype was conserved in the TIGR4 and EF3030 background and under air-liquid interface conditions. Importantly, single Δ lctO mutants exhibited significantly greater translocation than Δ spxB mutants or wild-type strains across bronchial (Calu-3), alveolar (A549), and pharyngeal (Detroit 562) epithelial models. Enhanced translocation correlated with increased bacterial adherence but was independent of capsule expression, extracellular H₂O₂ production, pneumolysin, or tight junction disruption, as evidenced by stable transepithelial electrical resistance, lack of caspase-3/7 activation, and preserved host-cell viability (SYTOX staining) at early time points. High-resolution confocal microscopy revealed intracellular Δ lctO pneumococci localized within N -acetylglucosamine/sialic acid (GN/SA)-containing compartments as early as 1 h post-infection. In murine macrophages, Δ lctO mutants were phagocytosed at rates similar to wild-type bacteria but induced greater pneumolysin-dependent cytotoxicity at 24 h. These findings demonstrate that LctO functions as a metabolic checkpoint that restrains pneumococcal invasion of respiratory epithelia, revealing a previously unrecognized role for lactate oxidase in controlling the transition from colonization to invasive disease.
Authors
- Eva Bengtén (ORCID: https://orcid.org/0000-0001-9618-0197)
- Jason W. Rosch (ORCID: https://orcid.org/0000-0002-1798-1760)
- 健一 竹下
- Landon Murin
- Babek Alibayov (ORCID: https://orcid.org/0009-0006-2085-6991)
- Verónica Roxana Flores-Vega (ORCID: https://orcid.org/0000-0001-8830-4284)
- Ana G. Jop Vidal (ORCID: https://orcid.org/0009-0005-0785-0889)
- Roberto Rosales-Reyes (ORCID: https://orcid.org/0000-0001-9519-8766)
- Jorge Eugenio Vidal (ORCID: https://orcid.org/0000-0003-0573-5658)
Institutions
- St. Jude Children's Research Hospital (US)
- University of Mississippi Medical Center (US)
- Universidad Nacional Autónoma de México (MX)
Publication Details
- Journal
- Infection and Immunity
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1128/iai.00416-26
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- National Institutes of Health
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- National Institute of Allergy and Infectious Diseases